NSEDisclosure under SEBI Takeover Regulations1 Jul 2026 · 1 Jul 2026, 11:14 am

Disclosure under SEBI Takeover Regulations

Gujarat Themis Biosyn Limited · GUJTHEM

✦ AI SummaryRegulatory

Gujarat Themis Biosyn Limited's promoter, Sachin D. Patel, has made a disclosure under SEBI Takeover Regulations for acquiring 24,97,190 equity shares from Themis Medicare Limited, citing exemption for inter se transfer among promoters and promoter group.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sachin D. Patel has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Attachments (1)

📄

team_sandeshc_01072026110753_disc.pdf

pdf

Download →
View document text
Sachin D. Patel Chayya, 67 Swastik Society, N.S. Road No.5, JVPD Scheme, Next to Joy Elegance Building, Vile Parle (West), Mumbai - 400056, Maharashtra. 30th June, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Scrip Code: 506879 Bandra (East), Mumbai- 400051 Symbol:GUJTHEM Email Id: corp.relations@bseindia.com Email Id: takeover@nse.co.in Dear Sir / Madam, Sub:- Disclosures under Regulation 10(6) – Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. In reference to the caption subject matter and aforementioned reference details, we, the undersigned are enclosing herewith the disclosure under Regulation 10(6) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("SAST Regulations"). The acquirer had already made prior Intimation of Inter Se Transfer on 23rd June, 2026. You are requested to take the same on your record and oblige. Thanking you, Yours faithfully, Sachin D. Patel Acquirer Vineet Gawankar Company Secretary and Compliance Officer Gujarat Themis Biosyn Limited 69/C GIDC Industrial Estate, Vapi – 396 195, Dist. Valsad, Gujarat, India cfoassist@themismedicare.com Encl.: As above Disclosures under Regulation 10(6) –Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. 1. Name of the Target Company (TC) Gujarat Themis Biosyn Limited 2. Name of the acquirer(s) Sachin D. Patel 3. Name of the stock exchange where shares of BSE Ltd. the TC are listed National Stock Exchange of India Limited 4. Details of the transaction including rationale, 24,97,190 equity shares acquired if any, for the transfer/ acquisition of shares. Inter-se transfer among the Promoter and Promoter Group. 5. Relevant regulation under which the acquirer Regulation 10(1)(a)(i) - immediate Relative is exempted from making open offer. of the Promoters. 6. Whether disclosure of proposed acquisition Disclosures required Whether the was required to be made under regulation 10 to be made under disclosures under (5) and if so, regulation 10(5) – regulation 10(5) are - whether disclosure was made and whether it actually made was made within the timeline specified under Yes, disclosure under the regulations. Yes regulation 10(5) have - date of filing with the stock exchange. been mate 4 (four) working days prior to the transaction to the stock exchanges. Date of filing: 23rd June, 2026 7. Details of acquisition a. Name of the transferor / seller Themis Medicare Limited b. Date of acquisition 30th June, 2026 c. Number of shares/ voting rights in 24,97,190 respect of the acquisitions from each person mentioned in 7(a) above d. Total shares proposed to be acquired / 2.29 actually acquired as a % of diluted share capital of TC e. Price at which shares are proposed to be Rs. 400.45 acquired / actually acquired 8. Shareholding details Pre-Transaction Post-Transaction No. of % No. of % w.r.t shares held w.r.t shares held total total share share capital capital of TC of TC a. Each Acquirer / Transferee (*) Sachin D. Patel 10 0.00 24,97,200 2.29% b. Each Seller / Transferor Themis Medicare limited 2,52,72,037 23.19 2,27,74,847 20.90% Note: This disclosure is in relation to exemption for inter se transfer of shares between promoters and promoter group in compliance with Reg 10 / applicable provisions of the SEBI Takeover Regulation. Note: (*) Shareholding of each entity shall be shown separately and then collectively in a group. The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers. Sachin D. Patel Acquirer Place: Mumbai Date: 30.06.2026